Former FDA CDRH Medical Device Expert Joins Camargo

Camargo Pharmaceutical Services, the most experienced global strategist in the drug development industry specializing in the 505(b)(2) approval pathway, has helped Medicines360 gain FDA approval for their hormonal intrauterine contraceptive device. This intrauterine contraceptive device is important because it is a high quality product which will reach underserved women in 340B family planning clinics, and is being made available to these clinics at an affordable price of $50.